Yondelis (trabectedin)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) July 2016 WARNINGS AND PRECAUTIONS Hepatotoxicity Assess LFTs prior to each administration of YONDELIS and as clinically...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts